The Latest Breaking News from Bayer

The Supreme Court has rejected Bayer's appeal to shut down thousands of lawsuits claiming that its Roundup weedkiller causes cancer.

Bayer inherited Roundup and the litigation when it acquired Monsanto in 2018

The U.S. Supreme Court will likely reveal its decision over offering a clean chit to Bayer A.G.'s (OTC:BAYZF) Roundup weedkiller, Reuters reports. Bayer sought the review of an appeals court that sustained $25 million in damages awarded to a user of glyphosate-based weedkiller Roundup, who blamed his cancer on the product. Bayer urged…

The U.S. Supreme Court could announce as soon as Monday whether it will hear Bayer's bid to dismiss claims its Roundup weedkiller causes cancer as the company seeks to avoid potentially billions of dollars more in damages and payouts.

European Chemical Agency’s positive assessment for continued sale of substance is flawed, say environmental campaigners

Mikel Arteta's Arsenal are looking to sign at least one new centre-forward this summer after missing out on Champions League qualification to bitter rivals Tottenham

Here's a roundup of top developments in the biotech space over the last 24 hours:

Merck stock has reinvigorated on the company's plans in heart disease. Will its efforts be enough as Keytruda goes off patent?

Intrauterine devices (IUDs) are small T-shaped plastic devices containing either copper or a low dose of progestogen hormone. Lasting five to ten years, they provide highly effective contraception and are chosen by increasing numbers of users of all ages from adolescence to perimenopause.